Edition:
United States

McKesson Corp (MCK.N)

MCK.N on New York Stock Exchange

161.20USD
26 May 2017
Change (% chg)

$-1.16 (-0.71%)
Prev Close
$162.36
Open
$161.83
Day's High
$162.90
Day's Low
$161.13
Volume
227,259
Avg. Vol
420,194
52-wk High
$199.22
52-wk Low
$114.54

Latest Key Developments (Source: Significant Developments)

Uniprix shareholders approve at 95% Mckesson Canada's bid to acquire Uniprix
Tuesday, 16 May 2017 05:18pm EDT 

May 16 (Reuters) - Mckesson Corp :At shareholder meeting, shareholders approved 95% to Mckesson Canada's bid to acquire all outstanding shares of Uniprix.  Full Article

Mckesson Canada announces plan to acquire Uniprix
Wednesday, 12 Apr 2017 01:15pm EDT 

Mckesson Canada : Mckesson Canada announces plan to acquire Uniprix, strengthening the future of independent pharmacy in quebec .Mckesson Canada - as part of acquisition, individual pharmacies will remain independently owned.  Full Article

Mckesson anticipates recording pre-tax gain of about $2.9 to $3.5 bln in Q4
Thursday, 2 Mar 2017 11:05am EST 

Mckesson Corp : As a result of net gain from transaction, co to add about $10.70-$12.35 in Q4 GAAP earnings per share from continuing operations . Mckesson provides financial update to reflect creation of a new healthcare information technology company . Sees FY 2017 earnings per share $20.35 to $22.50 from continuing operations . Q4 earnings per share view $3.15 -- Thomson Reuters I/B/E/S . Previous fiscal 2017 guidance range updated to reflect timing effect related to closing of transaction . In conjunction with creation of new company, change healthcare raised approximately $6.1 billion in debt . In its Q4 results, Mckesson anticipates recording a pre-tax gain of approximately $2.9 billion to $3.5 billion . Mckesson owns approximately 70 pct of change healthcare, with remaining equity ownership held by CHC stockholders . Sees 2017 earnings per share of $12.45 to $12.75/diluted share, which excludes about $1.28 to $1.30 in charges to adjusted earnings related to goodwill impairment . Mckesson's 70 pct share of change healthcare's initial annual interest expense run rate is expected to be approximately $200 million . Mckesson will account for its equity share of change healthcare's earnings on a one-month lag . Mckesson says non-cash adjustment from transaction close process to reduce co's reported earnings in fiscal 2018 by approximately $140 million to $170 million.  Full Article

Mckesson announces purchase of CoverMyMeds
Thursday, 26 Jan 2017 07:00am EST 

McKesson Corp : McKesson announces purchase of CoverMyMeds, a Francisco Partners portfolio company . McKesson Corp - deal for to $1.4 billion .Once transaction closes, CoverMyMeds CEO Matt Scantland will continue to lead CoverMyMeds with existing leadership team.  Full Article

McKesson to acquire CoverMyMeds for about $1.1 bln
Wednesday, 25 Jan 2017 04:10pm EST 

McKesson Corp - : McKesson reports fiscal 2017 third-quarter results . Q3 adjusted earnings per share $3.03 . Q3 gaap earnings per share $2.86 from continuing operations . Q3 revenue $50.1 billion versus i/b/e/s view $50.5 billion . Q3 earnings per share view $2.91 -- Thomson Reuters I/B/E/S . Sees FY 2017 adjusted earnings per share $12.60 to $12.90 from continuing operations . Sees FY 2017 gaap earnings per share $9.80 to $10.30 from continuing operations . To acquire CoverMyMeds for approximately $1.1 billion, or $0.9 billion net of incremental cash tax benefits . FY2017 earnings per share view $12.54 -- Thomson Reuters I/B/E/S . Deal includes a maximum $0.3 billion of consideration contingent upon CoverMyMeds' financial performance through fiscal year ending 2019 .CoverMyMeds provides electronic prior authorization solutions to pharmacies, providers, payers and pharma manufacturers.  Full Article

Innerworkings expands partnership with McKesson
Wednesday, 21 Dec 2016 09:13am EST 

Innerworkings Inc :Innerworkings Inc says expansion of its ongoing relationship with healthcare services provider Mckesson Corporation.  Full Article

McKesson and Change Healthcare announce termination of Hart-Scott-Rodino act waiting period for the creation of a new healthcare information technology company
Wednesday, 21 Dec 2016 08:30am EST 

McKesson Corp : McKesson and Change Healthcare announce termination of Hart-Scott-Rodino act waiting period for the creation of a new healthcare information technology company .Acquisition is expected to close in first half of calendar year 2017.  Full Article

Mckesson received request from U.S. DOJ pursuant to Hart-Scott-Rodino Antitrust improvements act
Tuesday, 6 Sep 2016 04:09pm EDT 

Mckesson Corp : Received a request for additional information and documentary material from u.s. Doj pursuant to hart-scott-rodino antitrust improvements act . Request from doj in connection with entry into a contribution and sale agreement, by and among mckesson, change healthcare, inc. .Both mckesson and change healthcare continue to expect transaction to be completed in first half of calendar year 2017.  Full Article

Mckesson Q1 GAAP EPS $2.88 from continuing operations
Wednesday, 27 Jul 2016 04:10pm EDT 

Mckesson Corp : Fy2017 earnings per share view $13.64 -- Thomson Reuters I/B/E/S . Reports Fiscal 2017 First-Quarter results . Q1 adjusted earnings per share $3.50 . Q1 GAAP earnings per share $2.88 from continuing operations . Q1 revenue $49.7 billion versus I/B/E/S view $50.36 billion . Sees fy 2017 adjusted earnings per share $13.43 to $13.93 excluding items . Sees fy 2017 GAAP earnings per share $10.70 to $11.60 from continuing operations . Q1 earnings per share view $3.33 -- Thomson Reuters I/B/E/S .Mckesson Corp sees GAAP earnings per diluted share between $10.70 to $11.60 for fiscal year ending march 31, 2017.  Full Article

UK's CMA says not refer Mckesson unit, AAH Pharma-UDG deal for phase 2 probe
Wednesday, 29 Jun 2016 10:27am EDT 

Competition and Markets Authority(CMA):UK's CMA says decided not to refer merger by Mckesson Corp unit AAH Pharmaceuticals of MASTA and Sangers to a Phase 2 investigation..  Full Article

More From Around the Web

BRIEF-McKesson sets regular quarterly dividend of $0.28/share

* Sets regular quarterly dividend of $0.28/share Source text for Eikon: Further company coverage: